What Drives the Value of a Shigella Vaccine? von Hausdorff, William P, Scheele, Suzanne, Giersing, Birgitte K

Volltext

Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015 von Giersing, Birgitte K, Modjarrad, Kayvon, Kaslow, David C, Moorthy, Vasee S

Volltext

Status of vaccine research and development of vaccines for Staphylococcus aureus von Giersing, Birgitte K, Dastgheyb, Sana S, Modjarrad, Kayvon, Moorthy, Vasee

Volltext

Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy von Hosangadi, Divya, Smith, Peter G., Giersing, Birgitte K.

Volltext

Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria von Malkin, Elissa M, Diemert, David J, McArthur, Julie H, Perreault, John R, Miles, Aaron P, Giersing, Birgitte K, Mullen, Gregory E, Orcutt, Andrew, Muratova, Olga, Awkal, May, Zhou, Hong, Wang, Jin, Stowers, Anthony, Long, Carole A, Mahanty, Siddhartha, Miller, Louis H, Saul, Allan, Durbin, Anna P

Volltext

Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group von Pavlinac, Patricia B, Rogawski McQuade, Elizabeth T, Platts-Mills, James A, Kotloff, Karen L, Deal, Carolyn, Giersing, Birgitte K, Isbrucker, Richard A, Kang, Gagandeep, Ma, Lyou-Fu, MacLennan, Calman A, Patriarca, Peter, Steele, Duncan, Vannice, Kirsten S

Volltext

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016 von Giersing, Birgitte K, Karron, Ruth A, Vekemans, Johan, Kaslow, David C, Moorthy, Vasee S

Volltext

How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making von Botwright, Siobhan, Kahn, Anna-Lea, Hutubessy, Raymond, Lydon, Patrick, Biey, Joseph, Karim Sidibe, Abdoul, Diarra, Ibrahima, Nadjib, Mardiati, Suwantika, Auliya A., Setiawan, Ery, Archer, Rachel, Kristensen, Debra, Menozzi-Arnaud, Marion, Mpia Bwaka, Ado, Mwenda, Jason M., Giersing, Birgitte K.

Volltext

How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella? von Giersing, Birgitte K., Porter, Chad K., Kotloff, Karen, Neels, Pieter, Cravioto, Alejandro, MacLennan, Calman A.

Volltext

The role of vaccines in reducing antimicrobial resistance: A review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens von Hasso-Agopsowicz, Mateusz, Sparrow, Erin, Cameron, Alexandra Meagan, Sati, Hatim, Srikantiah, Padmini, Gottlieb, Sami, Bentsi-Enchill, Adwoa, Le Doare, Kirsty, Hamel, Mary, Giersing, Birgitte K., Hausdorff, William P.

Volltext

Critical Needs in Advancing Shigella Vaccines for Global Health von MacLennan, Calman A, Talaat, Kawsar R, Kaminski, Robert W, Cohen, Dani, Riddle, Mark S, Giersing, Birgitte K

Volltext

Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016 von Giersing, Birgitte K, Vekemans, Johan, Nava, Samantha, Kaslow, David C, Moorthy, Vasee

Volltext

Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019 von Gottlieb, Sami L., Ndowa, Francis, Hook, Edward W., Deal, Carolyn, Bachmann, Laura, Abu-Raddad, Laith, Chen, Xiang-Sheng, Jerse, Ann, Low, Nicola, MacLennan, Calman A., Petousis-Harris, Helen, Seib, Kate L., Unemo, Magnus, Vincent, Leah, Giersing, Birgitte K.

Volltext

WHO consultation on ETEC and Shigella burden of disease, Geneva, 6–7th April 2017: Meeting report von Hosangadi, Divya, Smith, Peter G., Kaslow, David C., Giersing, Birgitte K.

Volltext

UPDATE ON THE CLINICAL DEVELOPMENT OF CANDIDATE MALARIA VACCINES von BALLOU, W. RIPLEY, AREVALO-HERRERA, MYRIAM, CARUCCI, DANIEL, RICHIE, THOMAS L, CORRADIN, GIAMPIETRO, DIGGS, CARTER, DRUILHE, PIERRE, GIERSING, BIRGITTE K, SAUL, ALLAN, HEPPNER, D. GRAY, KESTER, KENT E, LANAR, DAVID E, LYON, JEFF, HILL, ADRIAN V. S, PAN, WEIQING, COHEN, JOE D

Volltext

Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening von Riddle, Mark S., Louis Bourgeois, A., Clifford, Allison, Jeon, Suhi, Giersing, Birgitte K., Jit, Mark, Tufet Bayona, Marta, Ovitt, Jared, Hausdorff, William P.

Volltext

Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017 von Gottlieb, Sami L., Giersing, Birgitte K., Hickling, Julian, Jones, Rebecca, Deal, Carolyn, Kaslow, David C.

Volltext

Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact? von Giersing, Birgitte K, Kahn, Anna-Lea, Jarrahian, Courtney, Mvundura, Mercy, Rodriguez, Carmen, Okayasu, Hiromasa, Zehrung, Darin

Volltext

Vaccine value profile for Shigella von Hausdorff, William P., Anderson, John D., Bagamian, Karoun H., Bourgeois, A. Louis, Mills, Melody, Sawe, Frederick, Scheele, Suzanne, Talaat, Kawsar, Giersing, Birgitte K.

Volltext

Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection von Butkeviciute, Egle, Prudden, Holly J., Jit, Mark, Smith, Peter G., Kang, Gagandeep, Riddle, Mark S., Lopman, Benjamin A., Pitzer, Virginia E., Lanata, Claudio F., Platts-Mills, James A., Breiman, Robert F., Giersing, Birgitte K., Hasso-Agopsowicz, Mateusz

Volltext